Is OGEN (OGEN) Halal?
Shariah Screening — 5 Standards
Based on financial data from December 2025
| Standard | Debt Ratio | Cash Ratio | Receivables | Income | Status |
|---|---|---|---|---|---|
| AAOIFI | 8.8% / 30% | 23.1% / 30% | 0.0% / 30% | N/A | ✓ HALAL |
| DJIM | 8.8% / 33% | 23.1% / 33% | 0.0% / 33% | N/A | ✓ HALAL |
| MSCI | 22.3% / 33% | 58.7% / 33% | 0.0% / 33% | N/A | ✗ NOT HALAL |
| S&P | 8.8% / 33% | 23.1% / 33% | 0.0% / 33% | N/A | ✓ HALAL |
| FTSE | 22.3% / 33% | 58.7% / 33% | 0.0% / 50% | N/A | ✗ NOT HALAL |
Financial Highlights
Profitability
| Gross Margin | 0.0% | |
| Operating Margin | 0.0% | |
| Net Margin | 0.0% | |
| Return on Equity (ROE) | -243.9% | |
| Return on Assets (ROA) | -101.4% |
Cash Flow & Balance Sheet
| Operating Cash Flow | -$9M |
| Free Cash Flow | -$9M |
| Total Debt | $227,348 |
| Debt-to-Equity | 2.7 |
| Current Ratio | 5.6 |
| Total Assets | $10M |
Price & Trading
| Last Close | $0.58 |
| 50-Day MA | $0.79 |
| 200-Day MA | $1.25 |
| Avg Volume | 547K |
| Beta | 1.1 |
|
52-Week Range
$0.52
| |
About OGEN (OGEN)
Oragenics, Inc., a development-stage company, engages in the research and development of nasal delivery pharmaceutical therapies neurological conditions and infectious diseases in the United States. Its lead product is ONP-002, a fully synthetic, non-naturally occurring neurosteroid, which is lipophilic and can cross the blood-brain barrier to reduce swelling, oxidative stress, and inflammation while restoring proper blood flow through gene amplification for the treatment of mild traumatic brain injury. The company was formerly known as Oragen, Inc. Oragenics, Inc. was incorporated in 1996 and is headquartered in Lakewood Ranch, Florida.
Related Halal Stocks in Healthcare
Frequently Asked Questions
Is OGEN (OGEN) halal to invest in?
Based on our screening using AAOIFI Standard 21 (the strictest methodology), OGEN is Halal. The company passes all financial ratio thresholds for debt, cash, receivables, and impermissible income. We screen against all 5 major standards: AAOIFI, DJIM, MSCI, S&P, and FTSE.
What is OGEN's debt ratio?
OGEN's debt ratio is 8.8% under the AAOIFI standard (which uses market capitalization as the denominator). The AAOIFI threshold is 30%. Under MSCI and FTSE (which use total assets as the denominator), the debt ratio is 22.3%.
What are OGEN's key financial metrics?
OGEN has a market capitalization of $2M. Return on equity stands at -243.9%.
How often is the screening data updated?
Our screening data is updated regularly using the latest available financial statements and market data. Stock prices and market caps are refreshed frequently, while financial statements are updated quarterly when companies report earnings.
Disclaimer: HalalStockGuide.com provides Shariah compliance screening for educational and informational purposes only. This is not a fatwa, financial advice, or a recommendation to buy or sell any security. Screening results are based on publicly available financial data and established methodologies. Always consult a qualified Islamic scholar and a licensed financial advisor before making investment decisions.